Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

A687V EZH2 is a driver of histone H3 lysine 27 (H3K27) hypertrimethylation.

Ott HM, Graves AP, Pappalardi MB, Huddleston M, Halsey WS, Hughes AM, Groy A, Dul E, Jiang Y, Bai Y, Annan R, Verma SK, Knight SD, Kruger RG, Dhanak D, Schwartz B, Tummino PJ, Creasy CL, McCabe MT.

Mol Cancer Ther. 2014 Dec;13(12):3062-73. doi: 10.1158/1535-7163.MCT-13-0876. Epub 2014 Sep 24.

2.

Can Characteristics of Reciprocal Translocations Predict the Chance of Transferable Embryos in PGD Cycles?

Dul E, van Echten-Arends J, Groen H, Kastrop P, Wissen LA, Engelen J, Land J, Coonen E, van Ravenswaaij-Arts C.

J Clin Med. 2014 Apr 2;3(2):348-58. doi: 10.3390/jcm3020348.

3.

Preimplantation genetic diagnosis for X;autosome translocations: lessons from a case of misdiagnosis.

Van Echten-Arends J, Coonen E, Reuters B, Suijkerbuijk RF, Dul EC, Land JA, van Ravenswaaij-Arts CM.

Hum Reprod. 2013 Nov;28(11):3141-5. doi: 10.1093/humrep/det362. Epub 2013 Sep 18.

PMID:
24048012
4.

Development of a high-throughput screen to detect inhibitors of TRPS1 sumoylation.

Brandt M, Szewczuk LM, Zhang H, Hong X, McCormick PM, Lewis TS, Graham TI, Hung ST, Harper-Jones AD, Kerrigan JJ, Wang DY, Dul E, Hou W, Ho TF, Meek TD, Cheung MH, Johanson KO, Jones CS, Schwartz B, Kumar S, Oliff AI, Kirkpatrick RB.

Assay Drug Dev Technol. 2013 Jun;11(5):308-25. doi: 10.1089/adt.2012.501.

PMID:
23772552
5.

Chromosomal abnormalities in azoospermic and non-azoospermic infertile men: numbers needed to be screened to prevent adverse pregnancy outcomes.

Dul EC, van Echten-Arends J, Groen H, Dijkhuizen T, Land JA, van Ravenswaaij-Arts CM.

Hum Reprod. 2012 Sep;27(9):2850-6. doi: 10.1093/humrep/des222. Epub 2012 Jun 27.

PMID:
22740498
6.

Development of a cell-based high throughput luciferase enzyme fragment complementation assay to identify nuclear-factor-e2-related transcription factor 2 activators.

Xie W, Pao C, Graham T, Dul E, Lu Q, Sweitzer TD, Ames RS, Li H.

Assay Drug Dev Technol. 2012 Dec;10(6):514-24. doi: 10.1089/adt.2011.436. Epub 2012 May 10.

PMID:
22574653
7.

Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27).

McCabe MT, Graves AP, Ganji G, Diaz E, Halsey WS, Jiang Y, Smitheman KN, Ott HM, Pappalardi MB, Allen KE, Chen SB, Della Pietra A 3rd, Dul E, Hughes AM, Gilbert SA, Thrall SH, Tummino PJ, Kruger RG, Brandt M, Schwartz B, Creasy CL.

Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):2989-94. doi: 10.1073/pnas.1116418109. Epub 2012 Feb 8.

8.

The prevalence of chromosomal abnormalities in subgroups of infertile men.

Dul EC, Groen H, van Ravenswaaij-Arts CM, Dijkhuizen T, van Echten-Arends J, Land JA.

Hum Reprod. 2012 Jan;27(1):36-43. doi: 10.1093/humrep/der374. Epub 2011 Nov 10.

PMID:
22081244
9.

Structural model of the p14/SF3b155 ยท branch duplex complex.

Schellenberg MJ, Dul EL, MacMillan AM.

RNA. 2011 Jan;17(1):155-65. doi: 10.1261/rna.2224411. Epub 2010 Nov 9.

10.

Who should be screened for chromosomal abnormalities before ICSI treatment?

Dul EC, van Ravenswaaij-Arts CM, Groen H, van Echten-Arends J, Land JA.

Hum Reprod. 2010 Nov;25(11):2673-7. doi: 10.1093/humrep/deq258. Epub 2010 Sep 16.

PMID:
20847185
11.

Potent, selective and orally bioavailable dihydropyrimidine inhibitors of Rho kinase (ROCK1) as potential therapeutic agents for cardiovascular diseases.

Sehon CA, Wang GZ, Viet AQ, Goodman KB, Dowdell SE, Elkins PA, Semus SF, Evans C, Jolivette LJ, Kirkpatrick RB, Dul E, Khandekar SS, Yi T, Wright LL, Smith GK, Behm DJ, Bentley R, Doe CP, Hu E, Lee D.

J Med Chem. 2008 Nov 13;51(21):6631-4. doi: 10.1021/jm8005096. Epub 2008 Oct 9.

PMID:
18842034
12.

Development of dihydropyridone indazole amides as selective Rho-kinase inhibitors.

Goodman KB, Cui H, Dowdell SE, Gaitanopoulos DE, Ivy RL, Sehon CA, Stavenger RA, Wang GZ, Viet AQ, Xu W, Ye G, Semus SF, Evans C, Fries HE, Jolivette LJ, Kirkpatrick RB, Dul E, Khandekar SS, Yi T, Jung DK, Wright LL, Smith GK, Behm DJ, Bentley R, Doe CP, Hu E, Lee D.

J Med Chem. 2007 Jan 11;50(1):6-9.

PMID:
17201405
13.

Discovery of aminofurazan-azabenzimidazoles as inhibitors of Rho-kinase with high kinase selectivity and antihypertensive activity.

Stavenger RA, Cui H, Dowdell SE, Franz RG, Gaitanopoulos DE, Goodman KB, Hilfiker MA, Ivy RL, Leber JD, Marino JP Jr, Oh HJ, Viet AQ, Xu W, Ye G, Zhang D, Zhao Y, Jolivette LJ, Head MS, Semus SF, Elkins PA, Kirkpatrick RB, Dul E, Khandekar SS, Yi T, Jung DK, Wright LL, Smith GK, Behm DJ, Doe CP, Bentley R, Chen ZX, Hu E, Lee D.

J Med Chem. 2007 Jan 11;50(1):2-5.

PMID:
17201404
14.

Novel Rho kinase inhibitors with anti-inflammatory and vasodilatory activities.

Doe C, Bentley R, Behm DJ, Lafferty R, Stavenger R, Jung D, Bamford M, Panchal T, Grygielko E, Wright LL, Smith GK, Chen Z, Webb C, Khandekar S, Yi T, Kirkpatrick R, Dul E, Jolivette L, Marino JP Jr, Willette R, Lee D, Hu E.

J Pharmacol Exp Ther. 2007 Jan;320(1):89-98. Epub 2006 Oct 3.

PMID:
17018693
15.

Expression, purification, and characterization of an enzymatically active truncated human rho-kinase I (ROCK I) domain expressed in Sf-9 insect cells.

Khandekar SS, Yi T, Dul E, Wright LL, Chen S, Scott GF, Smith GK, Lee D, Hu E, Kirkpatrick RB.

Protein Pept Lett. 2006;13(4):369-76.

PMID:
16712513
16.

Radioligand binding and functional characterization of recombinant human NmU1 and NmU2 receptors stably expressed in clonal human embryonic kidney-293 cells.

Aiyar N, Disa J, Foley JJ, Buckley PT, Wixted WE, Pullen M, Shabon U, Dul E, Szekeres PG, Elshourbagy NA, Sarau HM, Appelbaum E, Bolaky J.

Pharmacology. 2004 Sep;72(1):33-41.

PMID:
15292653
17.

Identification of novel isoform-selective inhibitors within class I histone deacetylases.

Hu E, Dul E, Sung CM, Chen Z, Kirkpatrick R, Zhang GF, Johanson K, Liu R, Lago A, Hofmann G, Macarron R, de los Frailes M, Perez P, Krawiec J, Winkler J, Jaye M.

J Pharmacol Exp Ther. 2003 Nov;307(2):720-8. Epub 2003 Sep 15.

PMID:
12975486
18.

Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL.

Emery JG, McDonnell P, Burke MB, Deen KC, Lyn S, Silverman C, Dul E, Appelbaum ER, Eichman C, DiPrinzio R, Dodds RA, James IE, Rosenberg M, Lee JC, Young PR.

J Biol Chem. 1998 Jun 5;273(23):14363-7.

19.

Cloning and functional characterization of a novel human CC chemokine that binds to the CCR3 receptor and activates human eosinophils.

White JR, Imburgia C, Dul E, Appelbaum E, O'Donnell K, O'Shannessy DJ, Brawner M, Fornwald J, Adamou J, Elshourbagy NA, Kaiser K, Foley JJ, Schmidt DB, Johanson K, Macphee C, Moores K, McNulty D, Scott GF, Schleimer RP, Sarau HM.

J Leukoc Biol. 1997 Nov;62(5):667-75.

PMID:
9365122
20.
21.

Human osteoclasts, not osteoblasts, deposit osteopontin onto resorption surfaces: an in vitro and ex vivo study of remodeling bone.

Dodds RA, Connor JR, James IE, Rykaczewski EL, Appelbaum E, Dul E, Gowen M.

J Bone Miner Res. 1995 Nov;10(11):1666-80.

PMID:
8592943
22.
23.

[Psychopathological changes in dying persons].

Bukowczyk A, Dul E, Skoczek E.

Pol Tyg Lek. 1971 May 10;26(19):710-2. Polish. No abstract available.

PMID:
5088659
24.

Review of the drainage of the infected peritoneal cavity.

Randazzo AP, Dul E.

Int Surg. 1968 Oct;50(4):363-7. No abstract available.

PMID:
5724959
25.

Drainage of the infected peritoneal cavity.

RANDAZZO AP, DUL E.

J Int Coll Surg. 1951 Aug;16(2):321-9. No abstract available.

PMID:
14861477

Supplemental Content

Support Center